Last reviewed · How we verify

Hexafluorenium Bromide (hexafluronium)

Medpointe Pharm Hlc · FDA-approved active Quality 10/100

Hexafluorenium Bromide (generic name: hexafluronium) is a hexafluronium drug developed by Medpointe Pharm Hlc. It is currently FDA-approved.

At a glance

Generic namehexafluronium
SponsorMedpointe Pharm Hlc
Drug classhexafluronium
TargetAcetylcholinesterase, Acetylcholinesterase, Butyrylcholinesterase
Therapeutic areaNeuroscience
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Hexafluorenium Bromide

What is Hexafluorenium Bromide?

Hexafluorenium Bromide (hexafluronium) is a hexafluronium drug developed by Medpointe Pharm Hlc.

Who makes Hexafluorenium Bromide?

Hexafluorenium Bromide is developed and marketed by Medpointe Pharm Hlc (see full Medpointe Pharm Hlc pipeline at /company/medpointe-pharm-hlc).

What is the generic name of Hexafluorenium Bromide?

hexafluronium is the generic (nonproprietary) name of Hexafluorenium Bromide.

What drug class is Hexafluorenium Bromide in?

Hexafluorenium Bromide belongs to the hexafluronium class. See all hexafluronium drugs at /class/hexafluronium.

What development phase is Hexafluorenium Bromide in?

Hexafluorenium Bromide is FDA-approved (marketed).

What does Hexafluorenium Bromide target?

Hexafluorenium Bromide targets Acetylcholinesterase, Acetylcholinesterase, Butyrylcholinesterase and is a hexafluronium.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing